New Two-Drug attack on tough blood cancers
NCT ID NCT05038592
Summary
This study is testing a two-drug combination to control chronic myelomonocytic leukemia and related blood cancers. It aims to find the safest, most effective dose and see how well the treatment works. The treatment pairs a targeted drug that seeks out cancer cells with a standard chemotherapy. The goal is to better manage these diseases in adults who have not responded well to other treatments or are newly diagnosed with higher-risk forms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.